ALKEM

Alkem Laboratories Share Price

 

 

Invest in Alkem Laboratories with 3.77X leverage

Invest with MTF

Performance

  • Low
  • ₹5,396
  • High
  • ₹5,452
  • 52 Week Low
  • ₹4,492
  • 52 Week High
  • ₹5,934
  • Open Price₹5,415
  • Previous Close₹5,392
  • Volume36,411
  • 50 DMA₹5,628.73
  • 100 DMA₹5,574.84
  • 200 DMA₹5,455.75

Investment Returns

  • Over 1 Month -5.37%
  • Over 3 Month -4.4%
  • Over 6 Month + 0.42%
  • Over 1 Year + 18.42%

Smart Investing Starts Here Start SIP with Alkem Laboratories for Steady Growth!

Invest Now

Alkem Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.5
  • PEG Ratio
  • 2.7
  • Market Cap Cr
  • 65,151
  • P/B Ratio
  • 4.9
  • Average True Range
  • 146.46
  • EPS
  • 200.85
  • Dividend Yield
  • 0.9
  • MACD Signal
  • -27.98
  • RSI
  • 37.57
  • MFI
  • 38.54

Alkem Laboratories Financials

Alkem Laboratories Technicals

EMA & SMA

Current Price
₹5,449.00
+ 57 (1.06%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹5,593.43
  • 50 Day
  • ₹5,628.73
  • 100 Day
  • ₹5,574.84
  • 200 Day
  • ₹5,455.75

Resistance and Support

5374 Pivot Speed
  • R3 5,492.50
  • R2 5,447.00
  • R1 5,419.50
  • S1 5,346.50
  • S2 5,301.00
  • S3 5,273.50

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alkem Laboratories Ltd, is one of India’s largest pharmaceutical companies, known for its leading brands like Clavam and Pan-D. With 21 manufacturing facilities and global presence in over 50 countries, Alkem drives innovation with 500+ scientists across 5 R&D centers.

Alkem Laboratories has an operating revenue of Rs. 14,252.70 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 19% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at C which is evident from recent supply seen, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alkem Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results & Interim Dividend
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results
2025-05-29 Audited Results & Final Dividend
2025-02-07 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-02-20 INTERIM Rs.43.00 per share(2150%)Interim Dividend
2025-08-08 FINAL Rs.8.00 per share(400%)Final Dividend
2025-02-14 INTERIM Rs.37.00 per share(1850%)Interim Dividend
2024-08-10 FINAL Rs.5.00 per share(250%)Final Dividend
2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
View Alkem Laboratories Dividend History Arrow

Alkem Laboratories F&O

Alkem Laboratories Shareholding Pattern

51.2%
16.06%
3.96%
9.97%
0%
17.09%
1.72%

About Alkem Laboratories

  • NSE Symbol
  • ALKEM
  • BSE Symbol
  • 539523
  • Managing Director
  • Mr. Sandeep Singh
  • ISIN
  • INE540L01014

Similar Stocks to Alkem Laboratories

Alkem Laboratories FAQs

Alkem Laboratories share price is ₹5,449 As on 23 February, 2026 | 11:47

The Market Cap of Alkem Laboratories is ₹65151 Cr As on 23 February, 2026 | 11:47

The P/E ratio of Alkem Laboratories is 27.5 As on 23 February, 2026 | 11:47

The PB ratio of Alkem Laboratories is 4.9 As on 23 February, 2026 | 11:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23